INFUSYSTEM HOLDINGS INC (INFU) Stock Overview
USA - NYSEARCA:INFU - US45685K1025 - Common Stock
INFU Key Statistics, Chart & Performance
The current stock price of INFU is 10.5 USD. In the past month the price decreased by -2.6%. In the past year, price increased by 55.56%.
INFU Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.92 | 95.85B | ||
| CI | THE CIGNA GROUP | 10.2 | 76.51B | ||
| LH | LABCORP HOLDINGS INC | 18.68 | 23.50B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.96 | 21.12B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 130.51 | 17.11B | ||
| FMS | FRESENIUS MEDICAL CARE-ADR | 12.63 | 15.12B | ||
| HIMS | HIMS & HERS HEALTH INC | 73.9 | 13.36B | ||
| DVA | DAVITA INC | 13.48 | 9.34B | ||
| GH | GUARDANT HEALTH INC | N/A | 7.73B | ||
| CHE | CHEMED CORP | 20.21 | 6.59B | ||
| RDNT | RADNET INC | 207.5 | 5.75B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 38.01 | 4.98B |
Related stock screener links
About INFU
Company Profile
InfuSystem Holdings, Inc. engages in the provision of healthcare services. The company is headquartered in Rochester Hills, Michigan and currently employs 502 full-time employees. The company went IPO on 2006-06-15. Its segments include Patient Services and Device Solutions. Its core service within its Patient Services segment is its Oncology Business. Patient Services supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its Device Solutions segment’s core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment, sell treatment-related consumables, and provide biomedical recertification, maintenance and repair services for oncology practices and other healthcare site settings, including, home care and home infusion providers and others.
Company Info
INFUSYSTEM HOLDINGS INC
3851 West Hamlin Road
Rochester Hills MICHIGAN 48309 US
CEO: Richard DiIorio
Employees: 508
Phone: 12482911210
INFUSYSTEM HOLDINGS INC / INFU FAQ
What is the stock price of INFUSYSTEM HOLDINGS INC today?
The current stock price of INFU is 10.5 USD. The price increased by 1.55% in the last trading session.
What is the ticker symbol for INFUSYSTEM HOLDINGS INC stock?
The exchange symbol of INFUSYSTEM HOLDINGS INC is INFU and it is listed on the NYSE Arca exchange.
On which exchange is INFU stock listed?
INFU stock is listed on the NYSE Arca exchange.
What is the price forecast or stock price prediction for INFUSYSTEM HOLDINGS INC stock?
11 analysts have analysed INFU and the average price target is 13.6 USD. This implies a price increase of 29.52% is expected in the next year compared to the current price of 10.5. Check the INFUSYSTEM HOLDINGS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is INFUSYSTEM HOLDINGS INC worth?
INFUSYSTEM HOLDINGS INC (INFU) has a market capitalization of 214.51M USD. This makes INFU a Micro Cap stock.
How many employees does INFUSYSTEM HOLDINGS INC have?
INFUSYSTEM HOLDINGS INC (INFU) currently has 508 employees.
What are the support and resistance levels for INFUSYSTEM HOLDINGS INC (INFU) stock?
INFUSYSTEM HOLDINGS INC (INFU) has a support level at 9.77 and a resistance level at 10.7. Check the full technical report for a detailed analysis of INFU support and resistance levels.
Is INFUSYSTEM HOLDINGS INC (INFU) expected to grow?
The Revenue of INFUSYSTEM HOLDINGS INC (INFU) is expected to grow by 6.09% in the next year. Check the estimates tab for more information on the INFU EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy INFUSYSTEM HOLDINGS INC (INFU) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of INFU, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of INFU, evaluating the profitability, health, valuation and growth aspects
- INFUSYSTEM HOLDINGS INC (INFU) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- INFUSYSTEM HOLDINGS INC (INFU) Sales and EPS estimates to see what analysts future expectations are.
- INFUSYSTEM HOLDINGS INC (INFU) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- INFUSYSTEM HOLDINGS INC (INFU) Insider and Institutional Ownership to learn about the owners and their transactions.
- INFUSYSTEM HOLDINGS INC (INFU) Stock Chart to make your own analysis
- INFUSYSTEM HOLDINGS INC (INFU) Latest news and press-releases to stay up to date.
Does INFUSYSTEM HOLDINGS INC (INFU) stock pay dividends?
INFU does not pay a dividend.
When does INFUSYSTEM HOLDINGS INC (INFU) report earnings?
INFUSYSTEM HOLDINGS INC (INFU) will report earnings on 2025-11-05, before the market open.
What is the Price/Earnings (PE) ratio of INFUSYSTEM HOLDINGS INC (INFU)?
The PE ratio for INFUSYSTEM HOLDINGS INC (INFU) is 45.65. This is based on the reported non-GAAP earnings per share of 0.23 and the current share price of 10.5 USD. Check the full fundamental report for a full analysis of the valuation metrics for INFU.
What is the Short Interest ratio of INFUSYSTEM HOLDINGS INC (INFU) stock?
The outstanding short interest for INFUSYSTEM HOLDINGS INC (INFU) is 0.75% of its float. Check the ownership tab for more information on the INFU short interest.
INFU Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to INFU. When comparing the yearly performance of all stocks, INFU is one of the better performing stocks in the market, outperforming 93.48% of all stocks.
INFU Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to INFU. INFU scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
INFU Financial Highlights
Over the last trailing twelve months INFU reported a non-GAAP Earnings per Share(EPS) of 0.23. The EPS increased by 1816.67% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 3.63% | ||
| ROA | 5.03% | ||
| ROE | 9.3% | ||
| Debt/Equity | 0.48 |
INFU Forecast & Estimates
11 analysts have analysed INFU and the average price target is 13.6 USD. This implies a price increase of 29.52% is expected in the next year compared to the current price of 10.5.
For the next year, analysts expect an EPS growth of 160.1% and a revenue growth 6.09% for INFU